[ad_1]
The Nationwide Company for Meals and Medicine Administration and Management has raised the alarm over the circulation of suspected counterfeit Augmentin 625mg Tabs within the nation.
Based on NAFDAC, the product failed wanting the labeling necessities.
The alert signed by the administration of NAFDAC and titled ‘NAFDAC Alert And Sensitization Of The Public On Suspected Falsified Augmentin 625mg’ was obtained by our correspondent on the company’s web site.
NAFDAC stated the suspected falsified Augmentin which was manufactured in April 2021 would expire on April 2024.
It additionally famous that the batch variety of the falsified drug is 562626 with a NAFDAC registration number- 04-1928.
It stated “The product failed wanting the labeling necessities. No inscription “manufactured by” is written on the label -only the deal with.
“Manufacturing and Expiry dates don’t meet the appropriate format. No MAS scratch quantity for verification.
“The brand “gsk” shouldn’t be correctly positioned as on the unique. The listed info signifies the product is falsified and counterfeited.
“In view of the above, NAFDAC has notified all its formations within the zones and 36 states of the federation together with the FCT to hold out surveillance and mop up the falsified Augmentin tablets.”
It added, “Please observe that the real Augmentin 625mg has legible product labeling info together with date markings – expiration and manufactured dates, batch quantity and NAFDAC registration quantity.
“NAFDAC advise to wholesalers, distributors, and pharmacies is that medicines ought to be obtained from approved/licensed suppliers, elevated vigilance is hereby inspired inside the provide chain to keep away from infiltration of the falsified product. The merchandise’ authenticity, bodily situation and labels ought to be fastidiously checked.
“NAFDAC implores healthcare suppliers to make sure vigilance to forestall the administration of falsified merchandise to unsuspecting sufferers. Members of the general public in possession of the above suspected counterfeit product are suggested to discontinue sale or use and submit inventory to the closest NAFDAC workplace.
“Healthcare suppliers and the general public ought to notify the closest NAFDAC workplace of any info in regards to the distribution, sale, and use of the falsified model of the Augmentin product. Report any suspicion of adversarial drug response and substandard and falsified medicines to NAFDAC on 0800-162-3322 or e mail: [email protected]”
[ad_2]
Source link
